![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Wang, Lili; Lyu, Chen; Stadlbauer, Birgit; Buchner, Alexander; Nößner, Elfriede und Pohla, Heike 
ORCID: https://orcid.org/0000-0001-8296-2059
(2024):
Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p‐STAT3 in prostate cancer.
In: The Prostate, Bd. 84, Nr. 2: S. 131-147
[PDF, 6MB]
ORCID: https://orcid.org/0000-0001-8296-2059
(2024):
Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p‐STAT3 in prostate cancer.
In: The Prostate, Bd. 84, Nr. 2: S. 131-147
[PDF, 6MB]
Lyu, Chen; Wang, Lili; Stadlbauer, Birgit; Noessner, Elfriede; Buchner, Alexander und Pohla, Heike
(2022):
Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG).
In: Cancers, Bd. 14, Nr. 17
[PDF, 10MB]
Lyu, Chen; Wang, Lili; Stadlbauer, Birgit; Buchner, Alexander und Pohla, Heike
(2022):
A Pan-Cancer Landscape of ABCG2 across Human Cancers: Friend or Foe?
In: International Journal of Molecular Sciences, Bd. 23, Nr. 24
[PDF, 7MB]
Werner, Maxim; Lyu, Chen; Stadlbauer, Birgit; Schrader, Isabel; Buchner, Alexander; Stepp, Herbert; Sroka, Ronald und Pohla, Heike
(2022):
The role of Shikonin in improving 5-aminolevulinic acid-based photodynamic therapy and chemotherapy on glioblastoma stem cells.
In: Photodiagnosis and Photodynamic Therapy, Bd. 39, 102987
Wang, Lili; Liu, Yuhan; Lyu, Chen; Buchner, Alexander und Pohla, Heike
(2021):
Diagnostic and Prognostic Role of miR-192 in Different Cancers: A Systematic Review and Meta-Analysis.
In: Biomed Research International, Bd. 2021, 8851035
Wang, Lili; Stadlbauer, Birgit; Lyu, Chen; Buchner, Alexander und Pohla, Heike
(2020):
Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1.
In: American Journal of Cancer Research, Bd. 10, Nr. 11: S. 3784-3800